UNH · UnitedHealth · Q3 FY2026
UnitedHealth Lifts Operating Margin to 5.8% on Revenue 0.4% Below a Year Ago
Third-quarter revenue was 0.4% below a year earlier at $112.7 billion while GAAP earnings from operations rose 52% to $6.6 billion; the operating margin widened to 5.8% from 3.8%, and UnitedHealth raised its 2026 outlook.
- Published
- Oct 23, 2026
- Event
- Oct 13, 2026
- Quarter ended
- Sep 30, 2026
- Data as of
- Oct 13, 2026
Published becauseBlockhaven's first note on UnitedHealth's third quarter 2026 results, reported Oct 13, 2026: earnings rose sharply while revenue was 0.4% below a year earlier.
The Blockhaven read
UnitedHealth's profit improved sharply from a year earlier while its revenue edged lower. Revenue was 0.4% below the third quarter of 2025 at $112.7 billion, yet GAAP earnings from operations rose 52% to $6.6 billion, the operating margin widened to 5.8% from 3.8%, and the medical care ratio improved to 88.4% from 89.9%. UnitedHealth credits medical cost management, benefit changes and pricing, and its release also reports $610 million of net favorable reserve development, about 0.7 point of premiums on Blockhaven's arithmetic. Adjusted EPS of $4.69 and the raised full-year outlook point the same way. Against the second quarter, revenue rose from $112.0 billion to $112.7 billion, while earnings from operations fell from $8.0 billion to $6.6 billion.
Latest reported quarter
13-week quarter · Earnings release filed Oct 13, 2026
RevenueGAAP
- Latest
- $112.7 billion
- Year ago
- $113.2 billion
- Change
- −0.4% (Down year over year)
From the earnings release
Operating incomeGAAP
- Latest
- $6.56 billion
- Year ago
- $4.32 billion
- Change
- +52.1% (Up year over year)
From the earnings release
Net income to UNH shareholdersGAAP
- Latest
- $4.11 billion
- Year ago
- $2.35 billion
- Change
- +75.0% (Up year over year)
From the earnings release
Diluted EPSGAAP
- Latest
- $4.56
- Year ago
- $2.59
- Change
- +76.1% (Up year over year)
From the earnings release
Operating margin (GAAP)Derived
- Latest
- 5.8%
- Year ago
- 3.8%
- Change
- +201 bp (Up year over year)
| Measure | Basis | Latest quarter | Year ago | Change |
|---|---|---|---|---|
| RevenueFrom the earnings release | GAAP | $112.7 billion | $113.2 billion | −0.4% (Down year over year) |
| Operating incomeFrom the earnings release | GAAP | $6.56 billion | $4.32 billion | +52.1% (Up year over year) |
| Net income to UNH shareholdersFrom the earnings release | GAAP | $4.11 billion | $2.35 billion | +75.0% (Up year over year) |
| Diluted EPSFrom the earnings release | GAAP | $4.56 | $2.59 | +76.1% (Up year over year) |
| Operating margin (GAAP) | Derived | 5.8% | 3.8% | +201 bp (Up year over year) |
Revenue growth −0.4% against +0.4% in the prior quarter (year over year, GAAP).
Trend: Mixed. Revenue growth turned negative, operating margin widened, GAAP operating income improved and management raised its outlook.
GAAP unless labelled. Non-GAAP and company-defined measures are labelled.
What changed
- Revenue was $112.7 billion, 0.4% below the $113.2 billion of the third quarter of 2025 and above the $112.0 billion of the second quarter of 2026.
- GAAP earnings from operations were $6.6 billion, up 52.1% from $4.3 billion a year earlier. The GAAP operating margin was 5.8% against 3.8%, and the net margin was 3.6% against 2.1%.
- GAAP diluted EPS was $4.56 against $2.59 a year earlier (+76.1%). Adjusted EPS, UnitedHealth's non-GAAP measure, was $4.69 against $2.92 (+60.6%). UnitedHealth raised its full-year 2026 outlook, which now stands at no less than $19.50 of diluted EPS and $20.50 of adjusted EPS.
- The medical care ratio was 88.4% against 89.9% a year earlier, and the operating cost ratio was 12.8% against 13.5%.
Key facts
- Medical care ratio
- 88.4% (89.9% a year earlier) as reported
- Operating cost ratio
- 12.8% (13.5% a year earlier) as reported
- UnitedHealthcare operating margin
- 3.3% (2.1% a year earlier) as reported
- Optum operating margin
- 5.6% (3.6% a year earlier) as reported
Why it matters
UnitedHealth attributes the lower medical care ratio to medical cost management, benefit design changes and pricing. It also reports $610 million of net favorable reserve development related to 2026 dates of service, which on Blockhaven's arithmetic is about 0.7 percentage point of the quarter's $87.1 billion of premiums. UnitedHealthcare's operating margin was 3.3% against 2.1%, and Optum's was 5.6% against 3.6%.
Both segments reported lower revenue: UnitedHealthcare's was $86.3 billion against $87.1 billion, and Optum's was $66.9 billion against $69.2 billion. UnitedHealth attributes Optum Health's 10% revenue decline to fewer value-based care patients served. UnitedHealthcare served 48.3 million people against 50.1 million a year earlier.
Adjusted EPS of $4.69 is $0.13 above GAAP EPS. UnitedHealth adds back $0.41 per share of intangible amortization and removes $0.16 of net portfolio divestiture and South American impacts and $0.08 of restructuring and other items, with a $0.04 tax effect. Adjusted earnings from operations were $6.3 billion, a 5.6% margin against the 5.8% GAAP margin, because the adjustments remove net gains.
What to watch
- Medical care ratio at the next report against 88.4% this quarter, which included $610 million of net favorable reserve development: a ratio that holds without a comparable benefit would show the improvement does not rely on reserve development.
- Year-over-year revenue against the 0.4% decline now and 0.4% growth a quarter earlier: UnitedHealthcare membership and Optum Health revenue are the lines to follow, and a return to growth would change the picture.
- Illustrative arithmetic only: the nine-month EPS of $17.50 (GAAP) and $18.30 (adjusted) subtracted from the full-year outlook of at least $19.50 and $20.50 leaves $2.00 and $2.20. That is not fourth-quarter guidance or a floor for it: per-share amounts do not add exactly across periods.
Data and sources
GAAP figures, ratios and the outlook come from UnitedHealth's third quarter 2026 earnings release (Form 8-K, filed Oct 13, 2026). Adjusted EPS is a company-defined non-GAAP measure from the same release. Blockhaven used no outside forecasts, so no figure here is measured against market expectations.
Descriptive company facts. Not investment advice, a rating or a recommendation.